ArticleBritish journal of cancer2025

Aberrant PJA2-CHRM3 signaling creates a therapeutic vulnerability in gastric tumor.

Lingmeng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.